Lista de obras -

15-year-old boy with ocular palsy and headache. Invasive macroprolactinoma

artículo científico publicado en 1996

18F-DOPA PET/CT Physiological Distribution and Pitfalls: Experience in 215 Patients.

artículo científico publicado en 2016

A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC.

artículo científico publicado en 2015

A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas

artículo científico publicado en 2002

A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues.

artículo científico publicado en 2017

A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal

scientific article published on 02 October 2019

AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up

artículo científico publicado en 2014

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

artículo científico publicado en 2017

Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician's questions

artículo científico publicado en 2020

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.

artículo científico publicado en 2007

Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results

scientific article published on 01 November 2007

Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients

artículo científico publicado en 1999

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

artículo científico publicado en 2015

Clinical characterization of familial isolated pituitary adenomas.

artículo científico publicado en 2006

Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature.

artículo científico publicado en 2005

Differential expression of neurogenins and NeuroD1 in human pituitary tumours

scientific article published on 01 September 2007

Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors

artículo científico publicado en 2015

Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics.

artículo científico publicado en 1998

Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism

scientific article published on 01 March 1999

Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells

artículo científico publicado en 2018

Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells.

artículo científico publicado en 2016

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.

artículo científico publicado en 2009

Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.

artículo científico publicado en 2004

Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor response

artículo científico publicado en 2015

Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications

scientific article published on 01 March 2011

Giant prolactinomas presenting as skull base tumors.

artículo científico publicado en 2002

HMGA1-pseudogene expression is induced in human pituitary tumors.

artículo científico publicado en 2015

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.

artículo científico publicado en 2011

Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1

artículo científico publicado en 2003

Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly.

artículo científico publicado en 2003

Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients

artículo científico publicado en 2001

Mir-23b and miR-130b expression is downregulated in pituitary adenomas

artículo científico publicado en 2014

Mutations in theAryl Hydrocarbon Receptor Interacting ProteinGene Are Not Highly Prevalent among Subjects with Sporadic Pituitary Adenomas

article

Pituitary adenomas in young patients: when should we consider a genetic predisposition?

scientific article published on 01 November 2009

Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution

scientific article published on 13 December 2019

Prevalence of hypertension in acromegalic patients: clinical measurement versus 24-hour ambulatory blood pressure monitoring

artículo científico publicado en 1998

Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients

artículo científico publicado en 2012

Relationship between blood pressure and glucose tolerance in acromegaly.

artículo científico publicado en 2001

Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.

artículo científico publicado en 2013

Surgical treatment of pituitary tumors in the elderly: clinical outcome and long-term follow-up.

artículo científico publicado en 2002

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

artículo científico publicado en 2016

The genetics of pituitary adenomas.

artículo científico publicado en 2010

The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.

artículo científico publicado en 2005

Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg).

artículo científico publicado en 2000

Visual improvement during octreotide therapy in a case of episellar meningioma

scientific article published on 01 March 1998

p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours

artículo científico publicado en 1999

Lista de obras de

15-year-old boy with ocular palsy and headache. Invasive macroprolactinoma

18F-DOPA PET/CT Physiological Distribution and Pitfalls: Experience in 215 Patients.

A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC.

A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas

A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues.

A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal

AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician's questions

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.

Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results

Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

Clinical characterization of familial isolated pituitary adenomas.

Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature.

Differential expression of neurogenins and NeuroD1 in human pituitary tumours

Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors

Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics.

Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism

Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells

Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells.

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.

Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.

Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor response

Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications

Giant prolactinomas presenting as skull base tumors.

HMGA1-pseudogene expression is induced in human pituitary tumors.

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.

Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1

Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly.

Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients

Mir-23b and miR-130b expression is downregulated in pituitary adenomas

Mutations in theAryl Hydrocarbon Receptor Interacting ProteinGene Are Not Highly Prevalent among Subjects with Sporadic Pituitary Adenomas

Pituitary adenomas in young patients: when should we consider a genetic predisposition?

Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution

Prevalence of hypertension in acromegalic patients: clinical measurement versus 24-hour ambulatory blood pressure monitoring

Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients

Relationship between blood pressure and glucose tolerance in acromegaly.

Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.

Surgical treatment of pituitary tumors in the elderly: clinical outcome and long-term follow-up.

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

The genetics of pituitary adenomas.

The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.

Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg).

Visual improvement during octreotide therapy in a case of episellar meningioma

p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours